Found: 43
Select item for more details and to access through your institution.
Cancer Vaccine Development Program collaborations.
- Published in:
- 2010
- By:
- Publication type:
- journal article
A novel device developed, tested, and used for warming and maintaining intravenous fluids in a forward surgical team during Operation Enduring Freedom.
- Published in:
- 2006
- By:
- Publication type:
- journal article
A Novel Device Developed, Tested, and Used for Warming and Maintaining Intravenous Fluids in a Forward Surgical Team during Operation Enduring Freedom.
- Published in:
- Military Medicine, 2006, v. 171, n. 6, p. 500, doi. 10.7205/MILMED.171.6.500
- By:
- Publication type:
- Article
Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 9, p. 6015, doi. 10.1245/s10434-022-11800-0
- By:
- Publication type:
- Article
ASO Author Reflections: The Tumor Lysate, Particle-Loaded, Dendritic Cell Vaccine for Advanced-Stage Melanoma: Reflection on Personalized Cancer Vaccination.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 11, p. 6138, doi. 10.1245/s10434-021-09782-6
- By:
- Publication type:
- Article
A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 11, p. 6126, doi. 10.1245/s10434-021-09709-1
- By:
- Publication type:
- Article
Time-dependent Estimates of Recurrence and Survival in Colon Cancer: Clinical Decision Support System Tool Development for Adjuvant Therapy and Oncological Outcome Assessment.
- Published in:
- American Surgeon, 2014, v. 80, n. 5, p. 441, doi. 10.1177/000313481408000514
- By:
- Publication type:
- Article
Injecting Hope--A Review of Breast Cancer Vaccines.
- Published in:
- Oncology (08909091), 2016, v. 30, n. 5, p. 475
- By:
- Publication type:
- Article
Correlation of tumor microenvironment from biopsy and resection specimens in untreated colorectal cancer patients: a surprising lack of agreement.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1465, doi. 10.1007/s00262-020-02784-5
- By:
- Publication type:
- Article
Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/ neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 12, p. 1817, doi. 10.1007/s00262-008-0509-2
- By:
- Publication type:
- Article
The E75 HER2/ neu peptide vaccine.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 10, p. 1511, doi. 10.1007/s00262-008-0540-3
- By:
- Publication type:
- Article
Pattern of serum immunoreactivity against breast cancer cell lysates may predict severity of disease in breast cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 11, p. 1711, doi. 10.1007/s00262-007-0314-3
- By:
- Publication type:
- Article
Analysis of naïve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/ neu peptide (E75) and GM-CSF vaccine.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 2, p. 135, doi. 10.1007/s00262-006-0188-9
- By:
- Publication type:
- Article
Evaluation of the CD107 cytotoxicity assay for the detection of cytolytic CD8+ cells recognizing HER2/neu vaccine peptides.
- Published in:
- Breast Cancer Research & Treatment, 2005, v. 92, n. 1, p. 85, doi. 10.1007/s10549-005-0988-1
- By:
- Publication type:
- Article
Multi‐institutional, prospective, randomized, double‐blind, placebo‐controlled phase IIb trial of the tumor lysate, particle‐loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high‐risk melanoma patients: A subgroup analysis
- Published in:
- Cancer Medicine, 2021, v. 10, n. 13, p. 4302, doi. 10.1002/cam4.3969
- By:
- Publication type:
- Article
Final analysis of a phase I/IIa trial of the folate‐binding protein‐derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 10, p. 4678, doi. 10.1002/cam4.2378
- By:
- Publication type:
- Article
Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 01, doi. 10.3389/fimmu.2023.1090533
- By:
- Publication type:
- Article
Breast Cancer Vaccines.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 8, p. 1677, doi. 10.1002/cncr.22978
- By:
- Publication type:
- Article
Evaluation of the HER2/neu‐derived peptide GP2 for use in a peptide‐based breast cancer vaccine trialThis article is a US Government work and, as such, is in the public domain in the United States of America.The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or reflecting the views of the Department of the Army or the Department of Defense.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2309
- By:
- Publication type:
- Article
Clinical Development of the E75 Vaccine in Breast Cancer.
- Published in:
- Breast Care, 2016, v. 11, n. 2, p. 116, doi. 10.1159/000446097
- By:
- Publication type:
- Article
The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapy.
- Published in:
- Journal of Surgical Oncology, 2024, v. 130, n. 1, p. 109, doi. 10.1002/jso.27689
- By:
- Publication type:
- Article
Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters.
- Published in:
- Journal of Surgical Oncology, 2024, v. 129, n. 2, p. 244, doi. 10.1002/jso.27466
- By:
- Publication type:
- Article
Combat casualties in Afghanistan cared for by a single Forward Surgical Team during the initial phases of Operation Enduring Freedom.
- Published in:
- 2005
- By:
- Publication type:
- journal article
The 274th Forward Surgical Team experience during Operation Enduring Freedom.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Combat Casualties in Afghanistan Cared for by a Single Forward Surgical Team during the Initial Phases of Operation Enduring Freedom.
- Published in:
- Military Medicine, 2005, v. 170, n. 6, p. 462, doi. 10.7205/MILMED.170.6.462
- By:
- Publication type:
- Article
The 274th Forward Surgical Team Experience during Operation Enduring Freedom.
- Published in:
- Military Medicine, 2005, v. 170, n. 6, p. 451, doi. 10.7205/MILMED.170.6.451
- By:
- Publication type:
- Article
The most frequently requested precombat refresher training by the Special Forces medics during Operation Enduring Freedom.
- Published in:
- 2005
- By:
- Publication type:
- journal article
The Most Frequently Requested Precombat Refresher Training by the Special Forces Medics during Operation Enduring Freedom.
- Published in:
- Military Medicine, 2005, v. 170, n. 1, p. 31, doi. 10.7205/MILMED.170.1.31
- By:
- Publication type:
- Article
Extracorporeal shock wave therapy suppresses the early proinflammatory immune response to a severe cutaneous burn injury.
- Published in:
- International Wound Journal, 2009, v. 6, n. 1, p. 11, doi. 10.1111/j.1742-481X.2008.00540.x
- By:
- Publication type:
- Article
Chemoprevention in familial adenomatous polyposis: past, present and future.
- Published in:
- Familial Cancer, 2021, v. 20, n. 1, p. 23, doi. 10.1007/s10689-020-00189-y
- By:
- Publication type:
- Article
Clinical trial results of the HER-2/ neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 10, p. 2594, doi. 10.1002/cncr.26574
- By:
- Publication type:
- Article
Use of booster inoculations to sustain the clinical effect of an adjuvant breast cancer vaccine.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 3, p. 463, doi. 10.1002/cncr.25586
- By:
- Publication type:
- Article
A New Era in Anticancer Peptide Vaccines.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 9, p. 2071, doi. 10.1002/cncr.24988
- By:
- Publication type:
- Article
Results of the First Phase 1 Clinical Trial of the HER-2/neu Peptide (GP2) Vaccine in Disease-Free Breast Cancer Patients.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 2, p. 292, doi. 10.1002/cncr.24756
- By:
- Publication type:
- Article
Optimal Dose and Schedule of an HER-2/neu (E75) Peptide Vaccine to Prevent Breast Cancer Recurrence: From US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
- Published in:
- Cancer (0008543X), 2008, v. 113, n. 7, p. 1666, doi. 10.1002/cncr.23772
- By:
- Publication type:
- Article
The GP2 peptide: A HER2/ neu-based breast cancer vaccine.
- Published in:
- Journal of Surgical Oncology, 2012, v. 105, n. 5, p. 452, doi. 10.1002/jso.21723
- By:
- Publication type:
- Article
Standardized pretreatment breast MRI-accuracy and influence on mastectomy decisions.
- Published in:
- Journal of Surgical Oncology, 2011, v. 104, n. 7, p. 741, doi. 10.1002/jso.21960
- By:
- Publication type:
- Article
Breast cancer screening compliance among young women in a free access healthcare system.
- Published in:
- Journal of Surgical Oncology, 2008, v. 97, n. 1, p. 20, doi. 10.1002/jso.20895
- By:
- Publication type:
- Article
Development of a Bayesian Classifier for Breast Cancer Risk Stratification: A Feasibility Study.
- Published in:
- ePlasty: Open Access Journal of Plastic Surgery, 2010, v. 10, p. 203
- By:
- Publication type:
- Article
Breast Cancer Immunotherapy.
- Published in:
- Maedica - a Journal of Clinical Medicine, 2015, v. 10, n. 2, p. 185
- By:
- Publication type:
- Article
Therapeutic Breast Cancer Vaccines.
- Published in:
- BioDrugs, 2009, v. 23, n. 5, p. 277, doi. 10.2165/11313490-000000000-00000
- By:
- Publication type:
- Article
The most likely but largely ignored triggering factor for breast (or all) cancer invasion.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 4, p. 573, doi. 10.7150/jca.82291
- By:
- Publication type:
- Article
Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Ductal Adenocarcinoma.
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 3537, doi. 10.2147/OTT.S311661
- By:
- Publication type:
- Article